Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 16 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 2017.45 | 574 / 578 | 90% | 19.02 | 1039 / 1155 |
stomach | 93% | 349.49 | 333 / 359 | 71% | 11.63 | 204 / 286 |
uterus | 85% | 197.21 | 144 / 170 | 76% | 19.65 | 349 / 459 |
thymus | 92% | 330.29 | 602 / 653 | 66% | 9.12 | 399 / 605 |
breast | 93% | 344.36 | 427 / 459 | 57% | 8.42 | 638 / 1118 |
liver | 96% | 378.73 | 216 / 226 | 53% | 6.85 | 216 / 406 |
kidney | 63% | 173.56 | 56 / 89 | 79% | 23.35 | 709 / 901 |
intestine | 63% | 249.40 | 604 / 966 | 72% | 12.53 | 377 / 527 |
bladder | 71% | 233.86 | 15 / 21 | 61% | 14.52 | 308 / 504 |
prostate | 76% | 187.42 | 187 / 245 | 48% | 3.69 | 242 / 502 |
esophagus | 61% | 133.54 | 879 / 1445 | 62% | 8.17 | 114 / 183 |
lymph node | 0% | 0 | 0 / 0 | 100% | 164.05 | 29 / 29 |
spleen | 100% | 5835.36 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 527.39 | 1177 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 15796.34 | 899 / 929 | 0% | 0 | 0 / 0 |
pancreas | 20% | 32.41 | 67 / 328 | 76% | 10.25 | 135 / 178 |
skin | 19% | 30.64 | 343 / 1809 | 76% | 34.29 | 357 / 472 |
tonsil | 0% | 0 | 0 / 0 | 91% | 34.96 | 41 / 45 |
adrenal gland | 41% | 62.27 | 106 / 258 | 28% | 2.51 | 64 / 230 |
ovary | 22% | 42.74 | 39 / 180 | 40% | 3.82 | 172 / 430 |
heart | 61% | 135.59 | 523 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 51% | 140.51 | 681 / 1335 | 0% | 0 | 0 / 0 |
brain | 21% | 36.82 | 563 / 2642 | 24% | 3.28 | 172 / 705 |
muscle | 34% | 56.17 | 271 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 29% | 5.29 | 23 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051712 | Biological process | positive regulation of killing of cells of another organism |
GO_0051260 | Biological process | protein homooligomerization |
GO_0140507 | Biological process | granzyme-mediated programmed cell death signaling pathway |
GO_0001771 | Biological process | immunological synapse formation |
GO_0017038 | Biological process | protein import |
GO_0002418 | Biological process | immune response to tumor cell |
GO_0051607 | Biological process | defense response to virus |
GO_0001913 | Biological process | T cell mediated cytotoxicity |
GO_0006968 | Biological process | cellular defense response |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0002357 | Biological process | defense response to tumor cell |
GO_0006915 | Biological process | apoptotic process |
GO_0071806 | Biological process | protein transmembrane transport |
GO_0009306 | Biological process | protein secretion |
GO_0001772 | Cellular component | immunological synapse |
GO_0044194 | Cellular component | cytolytic granule |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_1904856 | Cellular component | cytolytic granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0031904 | Cellular component | endosome lumen |
GO_0042802 | Molecular function | identical protein binding |
GO_0022829 | Molecular function | wide pore channel activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0140911 | Molecular function | pore-forming activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRF1 |
Protein name | Perforin 1 Perforin-1 (P1) (Cytolysin) (Lymphocyte pore-forming protein) (PFP) Perforin |
Synonyms | PFP |
Description | FUNCTION: Pore-forming protein that plays a key role in granzyme-mediated programmed cell death, and in defense against virus-infected or neoplastic cells . Plays an important role in killing other cells that are recognized as non-self by the immune system, e.g. in transplant rejection or some forms of autoimmune disease . Can insert into the membrane of target cells in its calcium-bound form, oligomerize and form large pores . Promotes cytolysis and apoptosis of target cells by mediating the passage and uptake of cytotoxic granzymes . Facilitates the delivery of cationic cargo protein, while anionic or neural proteins are not delivered efficiently . Perforin pores allow the release of mature caspase-7 (CASP7) into the extracellular milieu (By similarity). . |
Accessions | V9TNI8 A0A1W2PR25 ENST00000638674.1 ENST00000441259.2 E6Y8C6 ENST00000373209.2 P14222 |